lintuzumab
seagen
['lintuzumab', 'leukemia', 'myeloid', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
a potential efficacy benefit has been observed with lintuzumab-ac225 plus salvage therapy for patients with relapsed/refractory acute myeloid leukemia. #aml #ash22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.